Corrigendum to: High Body Mass Index is Correlated with the Success of Vonoprazan-Based Second-Line Therapy for Helicobacter Pylori Infection (Tohoku J. Exp. Med., 253, 85-94, 2021, 10.1620/tjem.253.85)

Toyotaka Kasai, Sho Suzuki, Chika Kusano, Hisatomo Ikehara, Ryoji Ichijima, Motoki Ohyauchi, Masashi Kawamura, Yoshioki Yoda, Moriyasu Nakahara, Koichi Kawabe, Takuji Gotoda

Research output: Contribution to journal › Comment/debate

Fingerprint

Dive into the research topics of 'Corrigendum to: High Body Mass Index is Correlated with the Success of Vonoprazan-Based Second-Line Therapy for Helicobacter Pylori Infection (Tohoku J. Exp. Med., 253, 85-94, 2021, 10.1620/tjem.253.85)'. Together they form a unique fingerprint.

Medicine and Dentistry